Blood thinners after a heart stent for a blocked artery
Part of Heart & circulation clinical trials.
This study looks at whether taking two blood thinners (aspirin and clopidogrel) helps people who have had a stent placed to open a long-term total blockage in a heart artery. If you had a successful procedure to open such a blockage and are able to take aspirin, this trial might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have had a stent placed successfully to open a coronary artery that was completely blocked for a long time.
- You are able to take aspirin with another blood thinner.
- You are not taking prasugrel or ticagrelor (other blood thinners).
- You are not pregnant or breastfeeding.
- You are willing to give your written consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
This trial compares two blood-thinning medicines—clopidogrel and aspirin—after you have finished a short period of dual therapy following a special type of drug-eluting heart stent. It may help find which medicine works better and is safer for preventing future heart problems.
This trial tests if people who have been on two blood thinners (aspirin plus prasugrel or ticagrelor) for at least 90 days after getting a heart stent can safely switch to just one of those blood thinners. It aims to see if taking only one pill is as safe and effective as taking two.
This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.
Hear when a new Chronic Total Occlusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.